US 9662377
Therapeutic composition for treatment of glioblastoma
granted A61KA61K2039/54A61K2039/55511
Quick answer
US patent 9662377 (Therapeutic composition for treatment of glioblastoma) held by Regents of the University of Minnesota expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/54, A61K2039/55511, A61K2039/575, A61K2239/31